Advanz Hits Back Over £100m+ Fines For UK Liothyronine Pricing

Firm ‘Utterly Disagrees’ With CMA And Vows To Appeal Decision

 
• By Dave Wallace
  
The CMA announced fines of more than £100m over liothyronine pricing • Source: Almy
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from United Kingdom

More from Europe